EVALUASI PENGGUNAAN OBAT ANTIHIPERTENSI PASIEN PREEKLAMPSIA DI INSTALASI RAWAT INAP RSUD PROF. DR. W.Z JOHANNES KUPANG

  • Yovita Afriana Yani Universitas Citra Bangsa

Abstract

Preeclampsia is a disease with signs of hypertension, edema and proteinuria that arise due to pregnancy. Preeclampsia can occur in the third trimester of pregnancy but also happeds before or after pregnancy. The aims of this study to determine the pattern of using drugs and the suitability of the using antihypertensive in preeclampsia patients at the installation room of  Hospital. Prof Dr. W.Z Johannes Kupang.                Type of this research is descriptive research with using a retrospective approach. The sampling technique in this study uses purposive sampling. Data analysis was performed descriptively and compared with the Queensland Clinical Guideline reference standard of 2015 and POGI in 2016.                The results of research at Hospital Prof. Dr. WZ Johannes Kupang from 42 samples showed that patients who were at risk of developing preeclampsia were 20-35 years old (73,81%) with 28-37 weeks gestation (52,38%) who were diagnosed with severe preeclampsia (71,42%) and had a history of  hypertension (85,71%). He most widely used antihypertensive monotherapy is nifedipine (66,67%). Percentage of appropriateness of the use of antihypertensive drugs shows the right indication (80,96%), the right drug (69,04%), the right dose (80,96%), the right patient (80,96%) and  the ESO alert (100%).     Keywords: preeclampsia, rationality  

Downloads

Download data is not yet available.
Published
2021-02-26